The comparative effects of n-3 and n-6 polyunsaturated fatty acids on plasma fibrinogen levels: a controlled clinical trial in hypertriglyceridemic subjects.
- 1 August 1990
- journal article
- research article
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 9 (4) , 352-357
- https://doi.org/10.1080/07315724.1990.10720392
Abstract
It has previously been shown that fish oil supplementation, compared to olive oil, reduces plasma fibrinogen. Presented here are the results of a randomized, double-blind, crossover controlled trail that compared the effects of dietary n-3 and n-6 fatty acid supplementation on plasma fibrinogen levels in 10 patients with hyperlipoproteinemia types IIb or IV. Plasma fibrinogen levels showed statistically significant reductions during both the fish oil and corn oil treatment periods. Other variables related to hemostasis which showed no significant changes from baseline included tissue plasminogen activator activity and inhibitor, protein C antigen, antithrombin III activity, bleeding time, and platelet counts. These data confirm the two previous reports that fish oil supplementation is associated with reductions in plasma fibrinogen levels, thereby modifying a potential nonlipid risk factor for cardiovascular disease. Unlike previous reports, however, n-6 polyunsaturated fatty acids were also associated with significant reductions in fibrinogen levels. Therefore, it is premature to conclude that the fibrinogen-lowering effects of dietary fish oil are unique to n-3 polyunsaturated fatty acids.This publication has 37 references indexed in Scilit:
- Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Effect of Dietary Lipids on Arterial Thrombus Formation: Rationale for the Support of Drug Therapy by DietSeminars in Thrombosis and Hemostasis, 1988
- EFFECTS OF CHANGES IN SMOKING AND OTHER CHARACTERISTICS ON CLOTTING FACTORS AND THE RISK OF ISCHAEMIC HEART DISEASEThe Lancet, 1987
- Analysis of Risk Factors for Stroke in a Cohort of Men Born in 1913New England Journal of Medicine, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- The fibrinolytic system and coagulation during bezafibrate treatment of hypertriglyceridemiaAtherosclerosis, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Human monocytes are associated with the formation of fibrin.The Journal of Experimental Medicine, 1983
- Effect of treatment of hyperlipidaemia on haemostatic variables.BMJ, 1980
- Specific binding of soluble fibrin to macrophages.The Journal of Experimental Medicine, 1977